Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1086 of 1,261
  1. US 7214495

    Screening method

    Takeda Pharmaceutical Company Limited Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  2. US 7214687

    Quinuclidine derivatives and medicinal compositions containing the same

    ALMIRALL, LLC Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  3. US 7214784

    Protective antigens for the control of Ixodes species infestations

    The Board of Regents for Oklahoma State University Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  4. US 7214391

    Botanical extract compositions and process for preparing same

    USANA Health Sciences, Inc. Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  5. US 7214366

    Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics AL, Corporation Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  6. US 7216041

    Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket

    Vertex Pharmaceuticals Incorporated Β· Granted May 8, 2007 Β· Expires May 3, 2027

    granted
  7. US 7211432

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  8. US 7211402

    Transcription factor coactivator protein, p/CIP

    The Regents of the University of California Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  9. US 7211445

    Conjugation of biomolecules using diels-alder cycloaddition

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  10. US 7211599

    Use of etodolac to treat hyperplasia

    The Regents of the University of California Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  11. US 7211252

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

    The Board of Regents of the University of Texas System Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  12. US 7211255

    Contraceptives based on SP22 and SP22 antibodies

    United States of America The U.S. Environmental Protection Agency Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  13. US 7211192

    Hybrid organic-inorganic adsorbents

    The Regents of the University of California Β· Granted May 1, 2007 Β· Expires Apr 26, 2027

    granted
  14. US 7208161

    Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  15. US 7208289

    Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

    Rigel Pharmaceuticals, Inc. Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  16. US 7208145

    Polymeric reagents comprising a ketone or a related functional group

    Nektar Therapeutics AL, Corporation Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  17. US 7208602

    Gamma secretase inhibitors

    Pharmacopeia Drug Discovery, Inc. Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  18. US 7208600

    Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

    Vertex Pharmaceuticals Incorporated Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  19. US 7208313

    Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  20. US 7208612

    Crystals of LuxP and complexes thereof

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  21. US 7208579

    IL4 receptor antagonists for horse, dog and cat

    The Regents of the University of California Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  22. US 7208478

    Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

    The Regents of the University of California Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  23. US 7208515

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted
  24. US 7208501

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Almirall Prodesfarma S.A. Β· Granted Apr 24, 2007 Β· Expires Apr 19, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.